• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Section Contents Menu

Newsroom

FDA NEWS RELEASE

FOR IMMEDIATE RELEASE
P04-05
January 23, 2004

Media Inquiries: 301-827-6242
Consumer Inquiries: 888-INFO-FDA

FDA Warns Consumers Not to Feed Infants "Better than Formula Ultra Infant Immune Booster 117"

The Food and Drug Administration is warning consumers that a product, Better Than Formula Ultra Infant Immune Booster 117, sold over the internet as a dietary supplement should not be fed to infants. NSP Research Nutrition of Mt. Clemens, Michigan, sells the product as a dietary supplement. Even though NSP Research Nutrition labeled their product as "a dietary supplement," as a result of its labeling claims FDA is concerned that the product may be an infant formula. The term "Better than Formula," in the product name describes this product as a substitute for, or alternative to, other infant formulas.

In addition, the "mixing instructions and directions" printed on the label state that "As with adults, infants should have small feedings every 2 to 3 hours throughout the day and should never be overfed." This statement appears to represent the product for use as a meal and not as a dietary supplement. There are a myriad of other promotional claims that appear to describe this product as an infant formula.

Under the Federal Food, Drug, and Cosmetic Act, the term "infant formula" means a food which purports to be or is represented for special dietary use solely as a food for infants by reason of its simulation of human milk or its suitability as a complete or partial substitute for human milk." Any infant formula marketed must be registered with the FDA at least 90 days before marketing.

The manufacturer has not submitted a notification required under Section 412 of the Federal Food, Drug, and Cosmetic Act for use of this product as an infant formula. If this product is used as an infant formula, there are no assurances that have been provided to the agency by the manufacturer that this product as represented for use 1) would support growth of infants, 2) contains nutrients essential for infants that are required by law in infant formulas, and 3) is manufactured under good manufacturing practices. In addition, the label lists a number of ingredients that have not been evaluated for safe use in infant formula.

"Since the product has not been reviewed as an infant formula, its nutritional value and safety as an infant formula are unknown," said FDA Commissioner Mark B. McClellan, M.D., Ph.D. "We urge parents who have purchased this product to immediately stop feeding it to their infants."

To date, FDA is not aware of any illnesses or injuries associated with this product. FDA advises that consumers contact their health-care provider if they have any concerns about possible health problems or illness of their infant.

#
 

RSS Feed for FDA News Releases [what is RSS?]